Demand for Benign Prostatic Hyperplasia Surgical Devices is increasing because of minimal invasive therapies
Benign prostate hyperplasia (BPH) refers to the non-cancerous enlargement of prostate. The treatment option depends on various factors such as age of the patient, prostate gland size, and severity of the disease. According to an article published in Urologic Clinic of North America, 2016, BPH is a common problem that affects over 20% of men in the U.S., which is around 15 million men. The treatment option includes medication, surgery such as open prostatectomy, transurethral resection of the prostate (TURP), and minimally invasive therapies such as transurethral needle ablation (TUNA) and minimally invasive therapies such as laser therapy, radiofrequency ablation, implants and others. Benign Prostatic Hyperplasia Surgical Devices are most important as surgery for benign prostatic hyperplasia is common and generally very safe. However, there are risks with any surgery, such as those related to anesthesia. Benign prostatic hyperplasia surgery has a very high succe...